VANCOUVER, BC, Feb. 8, 2022 /CNW/ - Pontus Protein Ltd. (TSXV:
HULK) (OTCQB: HLKKF) (FSE: 8YC) ("Pontus" or the
"Company") is pleased to announce the appointment of Mr.
Frank Port as a Non-Executive member
of the Company's board of directors (the "Board").
Mr. Port brings to Pontus a wealth of knowledge and expertise
with over thirty-five years of executive and financial management
experience, including as Founder and CIO of Bridgeport Capital Inc.
and Opportunity Asset Management Inc.
"When you combine science, technology and innovation in emerging
markets such as bioscience, it is beyond captivating," stated Mr.
Port. "I'm excited to join the team; the potential here is
limitless. In 2021, we saw the devastation and destruction of too
many in the B.C. farming community due to flooding and extreme
climate changes. We need to protect our future. Pontus has an
innovative and enormous opportunity to contribute that applies
environmentally friendly technology."
Mr. Spencer Smyl, who has been a
Board member with Pontus since going public, has chosen to step
down as a Board member to focus on his other endeavours.
Commenting on the Board, Connor
Yuen, Pontus' CEO, said, "I'd like to thank Spencer Smyl for his support since the beginning
and for his continued support as we build Pontus. We welcome
Frank Port to our Board. His
extensive experience will support our continued growth as we move
into production and expansion into new facilities."
Pontus also announces the grant of stock options (collectively,
the "Options") to certain directors and consultants of the
Company to purchase up to an aggregate of 700,000 common shares
(each, a "Share") under the Company's Stock Option Plan. The
Options are exercisable at an exercise price of $0.16 per Share for a period of two years from
the date of grant. All Options vested immediately on the date of
grant.
About Pontus Protein Ltd.
Pontus Protein Ltd. is a Vancouver,
B.C. based agricultural technology company that will enable
millions to rethink their food choices while helping people do the
world a world of good. By offering sustainably grown plant based
food options that are nutritious and delicious, we're helping this
kind of diet become the norm.
Pontus is reinventing agriculture with their proprietary Closed
Environment Vertical Aquaponic System (CEVAS) – the farming of the
future. Pontus specializes in the indoor vertical farming of water
lentils that use 95% less water than traditional agriculture and no
pesticides or chemicals. Pontus is committed to solving the global
food crisis by providing access to sustainable indoor biosecure
pure plant based proteins. Pontus' water lentils can be harvested
every 24 hours, exceed organic certification, and can be grown in
any climate in a relatively small area. Our water lentil protein is
filled with antioxidants, minerals, vitamins and all the amino
acids, making a complete protein food source. Pontus aims to
revolutionize the plant based sector as the entire sector is
currently based on two main protein sources: soy and pea. Water
lentil protein is far superior to pea and soy protein. It contains
over 40% protein vs. 5-36% protein*, and Pontus aims to be the base
protein for plant based food products, leading to the movement
transitioning the world from meat based to plant based
proteins.
To learn more, please visit pontuswaterlentils.com.
On behalf of the Board of Directors
"Connor Yuen"
Connor Yuen, CEO
Pontus Protein Ltd.
Forward-Looking Information
Certain statements in this release are forward-looking
statements, which reflect management's expectations regarding the
Company. Forward-looking statements consist of statements that are
not purely historical, including any statements regarding beliefs,
plans, expectations or intentions regarding the future, including,
but not limited to, statements relating to Pontus' ability to
revolutionize the plant based sector and enable millions to rethink
their food choices. Such statements are subject to risks and
uncertainties that may cause actual results, performance or
developments to differ materially from those contained in the
statements, including risks related to factors beyond the control
of the Company. These risks include, but are not limited to, the
following: the unknown magnitude and duration of the effects of the
COVID-19 pandemic, the failure of Pontus to receive the necessary
approvals from the Canadian Food Inspection Agency for its products
and facilities, the inability to complete Pontus' Surrey Facility,
as well as other general business, economic, or market related
risks beyond the director control of the Company and which may
affect the Company's business, operations, or products. No
assurance can be given that any of the events anticipated by the
forward-looking statements will occur or, if they do occur, what
benefits the Company will obtain from them. The Company undertakes
no obligation to update forward-looking information if
circumstances or management's estimates or opinions should change,
unless required by law. The reader is cautioned not to place undue
reliance on forward-looking information.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in policies
of the TSX Venture Exchange) accept responsibility for the adequacy
or accuracy of this release.
SOURCE Pontus Protein Ltd.
